ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Brain Tumor Research Needs Stronger Interdisciplinary Collaboration, PRG Says.

November 17, 2000

Pryor Bill Embodies Drug Company Fears

July 8, 1994

NIAID, Vaccine Center Begin Phase I Trial Of AIDS Vaccine.

October 12, 2001

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984